Gastroesophageal Junction Carcinoma — Trials

Gastroesophageal Junction Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

706 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 231
Recruiting: 126
Ph III recruiting: 18
Growth YoY: +44.2%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03366012	Rapid Assessment of Esophageal Adenocarcinoma Risk Test(REACT)	terminated	N/A	51	Columbia UniversityOTHER	1	Nov 8, 2024	clinicaltrials
NCT04977401	EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection(EPSILON)	terminated	N/A	32	Erasme University HospitalOTHER	3	Oct 23, 2023	clinicaltrials